Clinical Research Directory
Browse clinical research sites, groups, and studies.
Cryoballoon vs. Rhythmia Guided Ablation for Recurrent AFib
Sponsor: Valley Health System
Summary
The purpose of this research is to evaluate whether cryoballoon ablation vs. radiofrequency ablation guided by high-fidelity mapping (Rhythmia) is the best treatment strategy to perform repeat ablation for recurrent atrial fibrillation after previously having undergone cryoballoon ablation.
Official title: Cryoballoon vs. Rhythmia Guided Ablation for Recurrent Atrial Fibrillation Following Initial Cryoballoon Pulmonary Vein Isolation
Key Details
Gender
All
Age Range
18 Years - 100 Years
Study Type
INTERVENTIONAL
Enrollment
9
Start Date
2018-11-27
Completion Date
2022-04-26
Last Updated
2026-06-24
Healthy Volunteers
No
Conditions
Interventions
ECG monitoring with a Kardia Mobile monitor
The participants in the study will undergo a total of two follow-up visits after ablation (approximately 3 and 6 months) with a 12-lead electrocardiogram at each visit. An assessment of rhythm will be performed with daily transmissions as well as subject-activated event recordings for symptoms with the Kardia Mobile smartphone based monitor. The Kardia Mobile System is an FDA-cleared, clinical grade mobile ECG monitor coupled with a smartphone app that is able to record a single-lead ECG and securely transmit the tracings to the study investigators via the Kardia Pro commercial (HIPPA compliant) remote monitoring service for clinicians.
Locations (3)
Iowa Heart Center
West Des Moines, Iowa, United States
The Valley Hospital
Paramus, New Jersey, United States
Peace Health
Springfield, Oregon, United States